Maison Solutions Inc. Class A Common Stock — News

MONTEREY PARK, CA / ACCESS Newswire / July 27, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announced that it has received written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the annual meeting requirement under Nasdaq Listing Rule 5620(a) and that the matter is now closed. Nasdaq previously notified the Company on May 6, 2026, that it was not in compliance with Nasdaq Listing Rule 5620(a), which requires the Company to hold an annual meeting of stockholders no later than one year after the end of its fiscal year.

accessnewswire.com - 2026-07-27 12:00:00

MONTEREY PARK, CA / ACCESS Newswire / July 24, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announced that it has signed a definitive agreement to establish Maison AI Limited, a majority-controlled technology platform focused on artificial intelligence applications for grocery retail, supply-chain management and enterprise operations. Upon completion of the contemplated formation and capitalization, Maison Solutions, through its wholly owned subsidiary AZLL LLC, is expected to own approximately 90.09% of Maison AI, providing the Company with strategic and operational control of the platform.

accessnewswire.com - 2026-07-24 09:00:00

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Adv

gurufocus.com - 2026-07-23 21:00:00

MONTEREY PARK, CA / ACCESS Newswire / July 20, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announced that, as previously approved by the stockholders of the Company, it will implement a 1-for-5 reverse stock split of its outstanding shares of Class A common stock, effective on July 22, 2026, at 12:01 a.m. Eastern Time (the "Reverse Split").

accessnewswire.com - 2026-07-20 09:00:00

July 15, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Maison Solutions, Inc. (NASDAQ: MSS) titled, “Putting the “AI” in Maison: A Leaner Store Base Meets a Smarter Grocery Platform”. The report can be accessed here. Maison Solutions, Inc. (NASDAQ: MSS) is a US-based specialty grocery retailer headquartered in Monterey Park, California, serving Asian American and other ethnic communities. Public since its October 2023 IPO, the company operates six supermarkets, three under the HK Good Fortune banner in Southern California and three under the Lee Lee International Supermarkets banner in Arizona. On July 3, 2026, MSS agreed to divest two loss-making California stores (San Gabriel and Monrovia), with closing expected by year-end 2026. The sale will leave one HK Good Fortune store alongside the three Arizona stores, which have performed materially better than the California locations and now contribute ~70% of sales, concentrating revenue in the healthier Arizona market and removing store-level losses from the divested California locations.

thenewswire.com - 2026-07-15 13:45:00

Half of planned clinical sites will be activated this month; more than 20 patients have been pre-identified across participating centers Company to hold Type D meeting with FDA to discuss a potential registrational pathway through the addition of Part B to the existing REO 033 trial design Part B will be a randomized study designed to support potential accelerated and full approval SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, an investigational, systemically active immunotherapy that promotes potentially protective immune responses, including the upregulation of key inflammatory cytokines resulting in the formation of tertiary lymphoid structures and the expansion of tumor-infiltrating lymphocytes, today provided a clinical and regulatory update on REO 033, the Company's randomized controlled study evaluating pelareorep in combination with folinic acid, fluorouracil and irinotecan (“FOLFIRI”) and bevacizumab for the second-line treatment of patients with Rat Sarcoma (“RAS”)-mutant, microsatellite stable (“MSS”) metastatic colorectal cancer. REO 033 builds upon the previously reported REO 022 study, which more than doubled historical standard-of-care benchmarks across progression-free survival, overall survival, duration of response, and objective response rate.1 -4 Based on these data, pelareorep has received Fast Track designation from the U.S. Food and Drug Administration (“FDA”) for this indication.

globenewswire.com - 2026-07-13 09:00:00

Shares of Maison Solutions Inc (NASDAQ:MSS) rose sharply in pre-market trading. Maison Solutions entered into an agreement to divest San Gabriel and Monrovia Store operations for $4.5 million as a part of strategic realignment.

benzinga.com - 2026-07-06 04:45:10

MONTEREY PARK, CA / ACCESS Newswire / July 3, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announced that its subsidiaries have entered into an asset purchase agreement to divest the assets and operations of the Company's San Gabriel and Monrovia store locations for an aggregate purchase price of $4.5 million, excluding inventory, which will be purchased separately pursuant to inventory purchase agreements. The closing of the transaction is expected to occur on or before December 31, 2026, subject to the terms and conditions of the Asset Purchase Agreement.

accessnewswire.com - 2026-07-03 09:50:00

[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study

gurufocus.com - 2026-06-25 08:00:00

MONTEREY PARK, CA / ACCESS Newswire / June 9, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announced a strategic collaboration with SupplyAi, an AI-native product company focused on the physical food supply chain, and MiniMax, a leading global artificial intelligence company with multimodal and agentic AI capabilities, to explore AI-native solutions for the North American food retail and supply chain industry. The contemplated collaboration is intended to allow the parties to explore AI solutions for food supply chain operators in North America, with a goal of supporting workflow automation, operational visibility, data-driven decision-making, customer enablement, and commercialization readiness across retail, wholesale, procurement, inventory, logistics, and related operating workflows.

accessnewswire.com - 2026-06-09 10:05:00

Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in

gurufocus.com - 2026-05-30 09:00:00

MONTEREY PARK, CA / ACCESS Newswire / May 25, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to customers in the United States, today announced that Alexandria Marie Lopez, Chief Financial Officer, has been named a 2026 nominee for the LA Executive Awards, presented by LA Times Studios and the Los Angeles Times Media Group. The LA Executive Forum & Leadership Awards brings together executives and entrepreneurs from the Los Angeles region for networking, strategic discussions, and recognition.

accessnewswire.com - 2026-05-25 09:00:00

MONTEREY PARK, CA / ACCESS Newswire / May 12, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announced that on May 11, 2026, it received written notification from The Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC stating that the Company has regained compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. Accordingly, the Company's Class A common stock will continue to be listed and traded on the Nasdaq Capital Market.

accessnewswire.com - 2026-05-12 10:00:00

SAN FRANCISCO and SUZHOU, China, May 10, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted a third Breakthrough Therapy Designation (BTD) to its first-in-class PD-1/IL-2α-bias bispecific fusion protein, IBI363, in combination with bevacizumab, for the treatment of patients with advanced microsatellite stable or proficient mismatch repair (MSS/pMMR) colorectal cancer (CRC) who have failed at least two prior lines of standard therapy. A Phase III clinical trial is about to initiate in China for this indication in the near term.

prnewswire.com - 2026-05-10 20:00:00

2L KRAS-Mutant MSS mCRC Demonstrates ~3–4x Improvement in Duration of Response vs. Historical 4–6 Month Benchmark Company Engaged with FDA to Support Potential Accelerated Approval Pathway in 2L RAS-Mutant MSS mCRC SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, an investigational, systemically delivered immunotherapy that has been shown to activate innate immune-sensing pathways, today announced new durability data in metastatic colorectal cancer (“mCRC”), demonstrating meaningful and sustained clinical benefit in patients with RAS-mutant, microsatellite-stable (“MSS”) disease.

globenewswire.com - 2026-05-04 09:00:00

MONTEREY PARK, CA / ACCESS Newswire / April 29, 2026 / Maison Solutions Inc. (NASDAQ:MSS) today provided notice of proposed settlement of derivative actions and settlement hearing. UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA IN RE MAISON SOLUTIONS INC.

accessnewswire.com - 2026-04-29 16:25:00

MONTEREY PARK, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Maison Solutions Inc. (NASDAQ:MSS) today provided notice of proposed settlement of derivative actions and settlement hearing.

globenewswire.com - 2026-04-29 16:17:00